ICDs (implantable cardioverter defibrillators) recalls could eventually have positive effects on US standards of medical device reporting
This article was originally published in Clinica
The safety issues surrounding Guidant's implantable cardioverter defibrillators (ICDs) could force all device companies to be more open about device faults if the powerful chairman of the Senate finance committee can bring his influence to bear.
You may also be interested in...
Can shaving ever be “friction free”? Not according to Procter & Gamble, which challenged in a complaint to the UK Advertising Standards Authority a claim made by a British cosmetics firm FFS that it provided a “friction free” shaving experience for women via its subscription razor service.
Work has started on UK-only regulations for the medtech and medicines sectors, to ensure that the regulatory framework not only functions but can also react swiftly to needs after the UK leaves the EU. This article is part two of two.